ArticleJournal of cellular and molecular medicine2020

Sotrastaurin, a PKC inhibitor, attenuates RANKL-induced bone resorption and attenuates osteochondral pathologies associated with the development of OA.

Cong Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.